Cosmos Health Inc. (COSM)
NASDAQ: COSM · Real-Time Price · USD
0.4360
-0.0150 (-3.33%)
At close: Mar 31, 2025, 4:00 PM
0.4391
+0.0031 (0.71%)
After-hours: Mar 31, 2025, 7:56 PM EDT
Cosmos Health Employees
Cosmos Health had 123 employees as of December 31, 2023. The number of employees increased by 21 or 20.59% compared to the previous year.
Employees
123
Change (1Y)
21
Growth (1Y)
20.59%
Revenue / Employee
$455,627
Profits / Employee
-$274,904
Market Cap
9.16M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
COSM News
- 4 weeks ago - Cosmos Health Expands Sky Premium Life Nutraceuticals Brand with 60 New SKUs as Global Growth Accelerates - Accesswire
- 5 weeks ago - Cosmos Health Announces It will not Proceed with an Offering Under Its Form S-1 - Accesswire
- 6 weeks ago - Cosmos Health Enters Final Development Phase of CCX0722 Weight Management Solution; Expected Product Launch in Q1 or Q2 2026, Gaining Access to Over $142 Billion Market - Accesswire
- 7 weeks ago - Cosmos Health Advances Cancer Treatment Innovation with Two New AI-Driven Patent Filings for Gliomas and Hematologic Malignancies; $25 Billion+ Global Market - Accesswire
- 7 weeks ago - Cosmos Health Strengthens Management Team with the Appointment of Veteran Executive Dimitris Moraitis as Vice President of Strategy & Operations - Accesswire
- 7 weeks ago - Cosmos Health Secures 10-Year Long-Term Contract Manufacturing Order from Provident Pharmaceuticals for 4 Additional Products, Totaling 8 Million Packs, Significantly Expanding High-Margin Revenue Backlog and Cash Flow Visibility - Accesswire
- 7 weeks ago - Cosmos Health Receives $578,460 Initial Purchase Order from Al Rabwa International for Sky Premium Life Food Supplements in Qatar - Accesswire
- 7 weeks ago - Cosmos Health Files New AI-Driven Patent Application for Multiple Sclerosis Treatment, Targeting $25 Billion+ Global Market - Accesswire